Evidence map›Paper›PMID 18940229›Full record

ReviewProgress in neurobiology2008

Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Mark F Mehler

Abstract readReview
In one paragraph

Review in Progress in neurobiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 285 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-International journal of molecular sciences · 2022
    Article
  15. Editorial: Sirtuins and brain homeostasis.Frontiers in physiology · 2022
    Article
  16. Epigenetics of neural differentiation: Spotlight on enhancers.Frontiers in cell and developmental biology · 2022
    Review
  17. Article
  18. Article
  19. Histone Methylation Regulation in Neurodegenerative Disorders.International journal of molecular sciences · 2021
    Review
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mark F MehlerInstitute for Brain Disorders and Neural Regeneration, Albert Einstein College of Medicine, Rose F. Kennedy Center 401, 1410 Pelham Parkway South, Bronx, NY 10461, USA. mehler@aecom.yu.edu
Albert Einstein College of Medicine · US

Funding

Support for MRRC - Biometry CoreP30HD001799 · NICHD · YESHIVA UNIVERSITY · PI FABER, DONALD S · 1985 to 2005
$6.5M
Mechanisms Regulating Astroglial Lineage DevelopmentR01MH066290 · NIMH · YESHIVA UNIVERSITY · PI MEHLER, MARK F · 2002 to 2006
$1.8M
REGULATION OF POSTNATAL CORTICAL MULTIPOTENT PROGENITORSR01NS038902 · NINDS · YESHIVA UNIVERSITY · PI MEHLER, MARK F · 1999 to 2002
$886k
NICHD NIH HHS P30 HD001799NIMH NIH HHS R01 MH066290NINDS NIH HHS R01 NS038902
6 · The paper itself

Abstract

Epigenetics and epigenomic medicine encompass a new science of brain and behavior that are already providing unique insights into the mechanisms underlying brain development, evolution, neuronal and network plasticity and homeostasis, senescence, the etiology of diverse neurological diseases and neural regenerative processes. Epigenetic mechanisms include DNA methylation, histone modifications, nucleosome repositioning, higher order chromatin remodeling, non-coding RNAs, and RNA and DNA editing. RNA is centrally involved in directing these processes, implying that the transcriptional state of the cell is the primary determinant of epigenetic memory. This transcriptional state can be modified not only by internal and external cues affecting gene expression and post-transcriptional processing, but also by RNA and DNA editing through activity-dependent intracellular transport and modulation of RNAs and RNA regulatory supercomplexes, and through trans-neuronal and systemic trafficking of functional RNA subclasses. These integrated processes promote dynamic reorganization of nuclear architecture and the genomic landscape to modulate functional gene and neural networks with complex temporal and spatial trajectories. Epigenetics represents the long sought after molecular interface mediating gene-environmental interactions during critical periods throughout the lifecycle. The discipline of environmental epigenomics has begun to identify combinatorial profiles of environmental stressors modulating the latency, initiation and progression of specific neurological disorders, and more selective disease biomarkers and graded molecular responses to emerging therapeutic interventions. Pharmacoepigenomic therapies will promote accelerated recovery of impaired and seemingly irrevocably lost cognitive, behavioral, sensorimotor functions through epigenetic reprogramming of endogenous regional neural stem cell fate decisions, targeted tissue remodeling and restoration of neural network integrity, plasticity and connectivity.

Indexed as

Nervous System DiseasesNervous System Physiological PhenomenaAnimalsChromatin Assembly and DisassemblyDNA MethylationEpigenesis, GeneticGene Expression RegulationHumans

Identifiers

PMID18940229
PMCPMC2636693
OpenAlexW2090123666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.